IVGSX | VIVAX | IVGSX / VIVAX | |
Total Expense Ratio | 0.89 | 0.17 | 524% |
Annual Report Gross Expense Ratio | 0.89 | 0.17 | 524% |
Fund Existence | 32 years | 33 years | - |
Gain YTD | -12.126 | 6.512 | -186% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 155M | 196B | 0% |
Annual Yield % from dividends | 2.72 | 2.06 | 132% |
Returns for 1 year | -8.09 | 7.90 | -102% |
Returns for 3 years | -7.29 | 25.93 | -28% |
Returns for 5 years | 18.15 | 68.56 | 26% |
Returns for 10 years | -14.61 | 114.64 | -13% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYCIX | 152.43 | 0.22 | +0.14% |
Rydex Consumer Products Inv | |||
GCEQX | 99.34 | -0.34 | -0.34% |
Green Century Equity Individual Investor | |||
JVAAX | 38.84 | -0.17 | -0.44% |
JPMorgan Value Advantage A | |||
IVCSX | 13.69 | -0.06 | -0.44% |
Voya Small Company Port I | |||
LAVSX | 16.18 | -0.09 | -0.55% |
Lord Abbett Fundamental Equity R4 |